Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Short-term Investments (2016 - 2024)

Cytosorbents' Short-term Investments history spans 4 years, with the latest figure at $5.0 million for Q4 2024.

  • Quarterly results put Short-term Investments at $5.0 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $5.0 million (changed N/A YoY), and the annual figure for FY2024 was $5.0 million, changed.
  • Short-term Investments for Q4 2024 was $5.0 million at Cytosorbents, up from $249000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $5.0 million in Q4 2024 to a low of $5.0 million in Q4 2024.